Patents by Inventor David Clapham
David Clapham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20170164591Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.Type: ApplicationFiled: February 28, 2017Publication date: June 15, 2017Inventors: Dejian REN, David CLAPHAM, David L. GARBERS, Timothy A. QUILL
-
Publication number: 20170107269Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.Type: ApplicationFiled: August 19, 2016Publication date: April 20, 2017Inventors: David CLAPHAM, Dejian REN
-
Patent number: 9618521Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.Type: GrantFiled: April 10, 2014Date of Patent: April 11, 2017Assignees: Children's Medical Center Corporation, Board of Regents, The University of Texas SystemInventors: Dejian Ren, David Clapham, David L. Garbers, Timothy A. Quill
-
Publication number: 20160353721Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper3) are disclosed. The CatSper3 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper3 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper3 activity, methods of genotyping subjects with respect to CatSper3, and methods of diagnosing and treating CatSper3-mediated disorders, including infertility. Related business methods are also disclosed.Type: ApplicationFiled: August 19, 2016Publication date: December 8, 2016Inventors: Magdalene M. MORAN, Jayhong A. CHONG, Ian S. RAMSEY, David CLAPHAM
-
Publication number: 20160353720Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper4) are disclosed. The CatSper4 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper4 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper4 activity, methods of genotyping subjects with respect to CatSper4, and methods of diagnosing and treating CatSper4-mediated disorders, including infertility. Related business methods are also disclosed.Type: ApplicationFiled: August 18, 2016Publication date: December 8, 2016Applicants: Children's Medical Center Corporation, Children's Medical Center CorporationInventors: Magdalene M. MORAN, Jayhong A. CHONG, Ian S. RAMSEY, David CLAPHAM
-
Patent number: 9125352Abstract: A method for the culture of somatic plant embryos comprising contacting said embryos with a culture medium containing a plasmolytic or near plasmolytic concentration of a sugar alcohol or a combination of sugar alcohols; and culturing said embryos in said culture medium for a time period suitable for the desired level of maturation to be achieved. Inositol is a preferable sugar alcohol.Type: GrantFiled: March 29, 2011Date of Patent: September 8, 2015Assignee: SweTree Technologies ABInventors: Ulrika Egertsdotter, David Clapham
-
Publication number: 20150219626Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper3) are disclosed. The CatSper3 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper3 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper3 activity, methods of genotyping subjects with respect to CatSper3, and methods of diagnosing and treating CatSper3-mediated disorders, including infertility. Related business methods are also disclosed.Type: ApplicationFiled: September 5, 2014Publication date: August 6, 2015Inventors: Magdalene M. MORAN, Jayhong A. CHONG, Ian S. RAMSEY, David CLAPHAM
-
Publication number: 20150219629Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.Type: ApplicationFiled: September 2, 2014Publication date: August 6, 2015Applicant: CHILDREN'S MEDICAL CENTER CORPORATIONInventors: David CLAPHAM, Dejian REN
-
Publication number: 20150212069Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper4) are disclosed. The CatSper4 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper4 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper4 activity, methods of genotyping subjects with respect to CatSper4, and methods of diagnosing and treating CatSper4-mediated disorders, including infertility. Related business methods are also disclosed.Type: ApplicationFiled: August 13, 2014Publication date: July 30, 2015Inventors: Magdalene M. MORAN, Jayhong A. CHONG, Ian S. RAMSEY, David CLAPHAM
-
Patent number: 9068018Abstract: Nucleic acid and protein sequences relating to a proton channel (Hv1) are disclosed. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the Hv1 gene and protein are disclosed. Also provided are methods of identifying modulators of Hv1 activity, methods of geno typing subjects with respect to Hv1, and methods of diagnosing and treating Hv1-mediated disorders.Type: GrantFiled: February 15, 2007Date of Patent: June 30, 2015Assignee: Children's Medical Center CorporationInventors: Ian S. Ramsey, Magdalene M. Moran, Jayhong A. Chong, David Clapham
-
Publication number: 20140363813Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.Type: ApplicationFiled: April 10, 2014Publication date: December 11, 2014Inventors: Dejian REN, David CLAPHAM, David L. GARBERS, Timothy A. QUILL
-
Patent number: 8859197Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper3) are disclosed. The CatSper3 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper3 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper3 activity, methods of genotyping subjects with respect to CatSper3, and methods of diagnosing and treating CatSper3-mediated disorders, including infertility. Related business methods are also disclosed.Type: GrantFiled: January 30, 2012Date of Patent: October 14, 2014Assignee: Children's Medical Center CorporationInventors: Magdalene M. Moran, Jayhong A. Chong, Ian S. Ramsey, David Clapham
-
Patent number: 8852860Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.Type: GrantFiled: May 30, 2012Date of Patent: October 7, 2014Assignee: Children's Medical Center CorporationInventors: David Clapham, Dejian Ren
-
Patent number: 8835105Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper4) are disclosed. The CatSper4 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper4 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper4 activity, methods of genotyping subjects with respect to CatSper4, and methods of diagnosing and treating CatSper4-mediated disorders, including infertility. Related business methods are also disclosed.Type: GrantFiled: February 10, 2012Date of Patent: September 16, 2014Assignee: Children's Medical Center CorporationInventors: Magdalene M. Moran, Jayhong A. Chong, Ian S. Ramsey, David Clapham
-
Patent number: 8729248Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper2) are disclosed. The CatSper2 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper2 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper2 activity, methods of genotyping subjects with respect to CatSper2, methods of diagnosing and treating CatSper2-mediated disorders, including infertility, as well as methods of doing business related to CatSper2-mediated disorders.Type: GrantFiled: January 29, 2008Date of Patent: May 20, 2014Assignees: Children's Medical Center Corporation, Board of Regents, The University of Texas SystemInventors: Dejian Ren, David Clapham, David L. Garbers, Timothy A. Quill
-
Publication number: 20130065306Abstract: A method for the culture of somatic plant embryos comprising contacting said embryos with a culture medium containing a plasmolytic or near plasmolytic concentration of a sugar alcohol or a combination of sugar alcohols; and culturing said embryos in said culture medium for a time period suitable for the desired level of maturation to be achieved. Inositol is a preferable sugar alcohol.Type: ApplicationFiled: March 29, 2011Publication date: March 14, 2013Inventors: Ulrika Egertsdotter, David Clapham
-
Publication number: 20120270236Abstract: Nucleic acid and protein sequences relating to a proton channel (HvI) are disclosed. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the HvI gene and protein are disclosed. Also provided are methods of identifying modulators of HvI activity, methods of geno typing subjects with respect to HvI, and methods of diagnosing and treating HvI-mediated disorders.Type: ApplicationFiled: February 15, 2007Publication date: October 25, 2012Applicant: CHILDREN'S MEDICAL CENTER CORPORATIONInventors: Ian S. Ramsey, Magdalene M. Moran, Jayhong A. Chong, David Clapham
-
Patent number: 8137918Abstract: Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper4) are disclosed. The CatSper4 protein is shown to be specifically expressed in sperm. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper4 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper4 activity, methods of genotyping subjects with respect to CatSper4, and methods of diagnosing and treating CatSper4-mediated disorders, including infertility. Related business methods are also disclosed.Type: GrantFiled: October 2, 2008Date of Patent: March 20, 2012Assignee: Children's Medical Center CorporationInventors: Magdalene M. Moran, Jayhong A. Chong, Ian S. Ramsey, David Clapham
-
Patent number: 8093242Abstract: The invention relates to 4-methylbenzenesulfonate salt of the compound of formula (I) in a crystalline form or a solvate thereof, pharmaceutical formulations containing them, their use in therapy and processes for preparing the same.Type: GrantFiled: August 4, 2009Date of Patent: January 10, 2012Assignee: GlaxoSmithKline LLCInventors: Clare Louise Anderton, Ronnie Maxwell Lawrence, David Clapham
-
Publication number: 20110136798Abstract: The invention relates to 4-methylbenzenesulfonate salt of the compound of formula (I) in a crystalline form or a solvate thereof, pharmaceutical formulations containing them, their use in therapy and processes for preparing the same.Type: ApplicationFiled: August 4, 2009Publication date: June 9, 2011Inventors: Clare Louise Anderton, Ronnie Maxwell Lawrence, David Clapham